This inventor holds 59 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 31 EPO patents, primarily in Kinase Inhibitors (CPC class A61K). Top assignees: Bristol-Myers Squibb Compnay, Innate Tumor Immunity, Inc., Birstol-Myers Squibb Company. Active years: 1998-2025.
Inventors with similar research interests:
Location History:
- Plainsboro, NJ (US) (1998)
- Princeton Junction, NJ (US) (2005 - 2024)
Company Filing History:
49 out of 3,736 
9 out of 21 
1 out of 2 Years Active: 1998-2025
Areas of Expertise:
Title: **Innovations and Contributions of Ashvinikumar V Gavai**
Introduction
Ashvinikumar V Gavai is a notable inventor based in Princeton Junction, NJ, with a remarkable portfolio of 55 patents. His work primarily focuses on innovative solutions within the field of medicine, particularly in targeting proliferative disorders. Gavai's contributions have significantly impacted drug development strategies, aiming to provide novel treatments for serious health conditions, including cancer.
Latest Patents
Among his latest patents is a significant invention related to NLRP3 modulators. This invention presents compounds of Formula (I), with specific variables defined in the patent text. These compounds serve as modulators of NLRP3, demonstrating potential use as medicaments for treating proliferative disorders such as cancer in subjects, including humans. The dual emphasis on treatment efficacy and specificity showcases the innovative nature of Gavai's work in pharmaceutical development.
Career Highlights
Throughout his career, Ashvinikumar V Gavai has made impactful contributions to renowned companies such as Bristol-Myers Squibb Company and Innate Tumor Immunity, Inc. His experience in these organizations reflects his dedication to advancing biopharmaceutical innovations.
Collaborations
Gavai has collaborated with talented professionals during his career, enhancing the quality and scope of his inventions. Notably, he has worked alongside colleagues Brian E. Fink and Yufen Zhao, embodying a spirit of teamwork and shared expertise in the research and development phase of pharmaceutical innovations.
Conclusion
In conclusion, Ashvinikumar V Gavai stands out as an influential inventor committed to tackling major healthcare challenges through innovative patenting. His advancements, particularly in the realm of NLRP3 modulation, highlight the potential for novel treatment strategies, ensuring his contributions will be recognized in the field of medical research.